CX₃CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis

Keyphrases

• Steatohepatitis 100%
• CX3CR1 100%
• Inflammatory Dendritic Cells 100%
• Monocyte-derived Cells 85%
• Tumor Necrosis Factor-α 71%
• Monocytes 28%
• Dendritic Cells 28%
• Methionine-choline-deficient 28%
• Inflammatory Monocytes 28%
• Parenchymal Injuries 28%
• Hepatic Tumor 28%
• Circulating Tumor DNA (ctDNA) 28%
• Sodium Hydrosulfide 28%
• CD11b+ 28%
• Factor Level 28%
• C57BL 14%
• Liver 14%
• Liver Injury 14%
• MHC Class II 14%
• Disease Progression 14%
• CD11c 14%
• Macrophage Cells 14%
• Monocyte-derived Macrophages 14%
• Hydrogen Sulfide 14%
• Transaminases 14%
• Nonalcoholic Steatohepatitis 14%
• Inflammation Injury 14%
• Hepatic Macrophages 14%
• CD11b+ Myeloid Cells 14%
• 4-fold 14%
• Proinflammatory Stimuli 14%
• CD45+ 14%
• Macrophage Markers 14%
• Inflamed Tissue 14%
• Inflammatory Macrophages 14%
• Macrophage Function 14%
• Monocyte Differentiation 14%
• Ly6C 14%
• H2S Donors 14%
• Combined Expression 14%
• CD11b 14%
• Fractalkine Receptor 14%

Immunology and Microbiology

• Dendritic Cell 100%
• Steatohepatitis 100%
• CX3CR1 100%
• Tumor Necrosis Factor Alpha 62%
• Macrophage 37%
• Methionine 25%
• C57BL 6 Mouse 12%
• Upregulation 12%
• CD11c 12%
• Myeloid 12%
• Macrophage Function 12%
• Fractalkine 12%
• Histiocyte 12%